Journal of Medicine and Life Science

Institute for Medical Science (제주대학교 의과학연구소)
권호 표지
DOI QR코드

DOI QR Code

Vesicoureteral reflux-associated hydronephrosis in a dialysis patient treated with percutaneous nephrostomy

  • Ju Hwan Oh (Division of Nephrology, Department of Internal Medicine, Presbyterian Medical Center) ;
  • Min Woo Kim (Department of Nuclear Medicine, Presbyterian Medical Center) ;
  • Jung Hwa Kim (Kim Jung Hwa Internal Medicine Office) ;
  • A Young Cho (Division of Nephrology, Department of Internal Medicine, Presbyterian Medical Center) ;
  • In O Sun (Division of Nephrology, Department of Internal Medicine, Presbyterian Medical Center) ;
  • Kwang Young Lee (Division of Nephrology, Department of Internal Medicine, Presbyterian Medical Center)
  • Received : 2022.02.03
  • Accepted : 2022.05.20
  • Published : 2022.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Patients with vesicoureteral reflux (VUR), the retrograde flow of urine from the bladder to the kidney, are known to experience renal scarring; this results in the worsening of renal function. Reflux nephropathy is a cause of chronic kidney disease, and VUR has also been observed in dialysis patients. VUR is a major underlying precursor condition of urinary tract infection (UTI) and is sometimes accompanied by hydronephrosis. However, there are no guidelines for the management of UTI due to VUR-associated hydronephrosis in patients with end-stage kidney disease. Herein, we report a case of UTI caused by VUR-associated hydronephrosis in a dialysis patient treated with percutaneous nephrostomy.

Keywords

References

  1. Williams G, Fletcher JT, Alexander SI, Craig JC. Vesicoureteral reflux. J Am Soc Nephrol 2008;19:847-62.
  2. Chantler C, Carter JE, Bewick M, Counahan R, Cameron JS, Ogg CS, et al. 10 years' experience with regular haemodialysis and renal transplantation. Arch Dis Child 1980;55:435-45.
  3. Deleau J, Andre JL, Briancon S, Musse JP. Chronic renal failure in children: an epidemiological survey in Lorraine (France) 1975-1990. Pediatr Nephrol 1994;8:472-6.
  4. Singhal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG. Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int 2000;20:429-38.
  5. Chavers BM, Solid CA, Gilbertson DT, Collins AJ. Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United States. J Am Soc Nephrol 2007;18:952-9.
  6. Hooton TM. Clinical practice. Uncomplicated urinary tract infection. N Engl J Med 2012;366:1028-37.
  7. Fenton S, Desmeules M, Copleston P, Arbus G, Froment D, Jeffery J, et al. Renal replacement therapy in Canada: a report from the Canadian Organ Replacement Register. Am J Kidney Dis 1995;25:134-50.
  8. Bakshandeh K, Lynne C, Carrion H. Vesicoureteral reflux and end stage renal disease. J Urol 1976;116:557-8.
  9. Yamashita K, Ishiyama Y, Yoshino M, Tachibana H, Toki D, Konda R, et al. Urinary tract infection in hemodialysis-dependent end-stage renal disease patients. Res Rep Urol 2022;14:7-15.
  10. Scherberich JE, Funfstuck R, Naber KG. Urinary tract infections in patients with renal insufficiency and dialysis - epidemiology, pathogenesis, clinical symptoms, diagnosis and treatment. GMS Infect Dis 2021;9:Doc07.
  11. Ramchandani P, Cardella JF, Grassi CJ, Roberts AC, Sacks D, Schwartzberg MS, et al. Quality improvement guidelines for percutaneous nephrostomy. J Vasc Interv Radiol 2003;14:S277-81.